NRX Pharmaceuticals Warrant (NRXPW)

• Market cap: $913K
• 1 day: -15.41%
• 5 days: 56.11%
• 1 month: -41.28%
• 3 months: -12.08%
• 6 months: -26.44%
• Year to date: -67.05%
• 1 year: -23.28%
• 5 years: -98.68%
• 10 years: -82.22%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.